NEW YORK, Dec. 7 (GenomeWeb News) - 454 Life Sciences and the Genome Sequencing Center at the Washington University School of Medicine plan to sequence disease-causing pathogens and study expression profiles of genes in mammalian cells and tissues, the partners said today.
The first part of the plan calls for GSC and 454 scientists to sequence and analyze the genomes of disease-causing pathogens using 454's Genome Sequencer 20 System. During the second part of the plan, scientists from the two partners will sequence RNA to assess the expression profiles of genes in mammalian cells and tissues.
Christopher McLeod, 454's president and CEO, noted that the cooperation "could be expanded to incorporate additional research topics in the future."
Financial details were not disclosed.